2005Traditional Chinese Drug Research and Clinical PharmacologyRequires access

Effects of Puerarin on the Expression of Glycogen Synthase Kinase- 3 in Skeletal Muscle of Rats with Insulin Resistance

Hang Su

Open publisher page 0 citations

Abstract

Objective To observe the effects of puerarin on the expression of glycogen synthase kinase- 3 (GSK- 3) in the skeletal muscle of rats with insulin resistance induced by high fat and sucrose diets. Methods 30 Wistar rats were randomly divided into three groups: normal group, model group and puerarin group, 10 rats in each group. The model group and puerarin group were fed with the high fat and sucrose diets for 4 weeks. Then puerarin group was treated with puerarin by abdominal injection (100 mg/kg) for 6 weeks. At the end of the experiment, GSK- 3 content was detected by Western blot analysis. Body weight, serum triglyceride and cholesterol levels, fasting plasma glucose and serum insulin concentrations were measured regularly and insulin sensitivity index was also computed as well. Results The outcome of Western blot analysis showed that the expression of GSK- 3 in the skeletal muscle of the model group increased by 70.20 % (P 0.01) compared with the normal group. After 6 weeks of puerarin treatment, the GSK- 3 content in the skeletal muscle of the puerarin group decreased by 26.54 % (P 0.01) compared with the model group and increased by 25.02 % (P 0.05) compared with the normal group. Conclusion Puerarin can lower the expression of GSK- 3 in the skeletal muscle of rats with insulin resistance, consequently promoting the ingestion and utilization of glucose and improving the insulin resistance.

About this research paper

What this paper is about

Objective To observe the effects of puerarin on the expression of glycogen synthase kinase- 3 (GSK- 3) in the skeletal muscle of rats with insulin resistance induced by high fat and sucrose diets. Methods 30 Wistar rats were randomly divided into three groups: normal group, model group and puerarin group, 10 rats in each group. The model group and puerarin group were fed with the high fat and sucrose diets for 4 weeks. Then puerarin group was treated with puerarin by abdominal injection (100 mg/kg) for 6 weeks. At the end of the experiment, GSK- 3 content was detected by Western blot analysis. Body weight, serum triglyceride and cholesterol levels, fasting plasma glucose and serum insulin concentrations were measured regularly and insulin sensitivity index was also computed as well. Results The outcome of Western blot analysis showed that the expression of GSK- 3 in the skeletal muscle of the model group increased by 70.20 % (P 0.01) compared with the normal group. After 6 weeks of puerarin treatment, the GSK- 3 content in the skeletal muscle of the puerarin group decreased by 26.54 % (P 0.01) compared with the model group and increased by 25.02 % (P 0.05) compared with the normal group. Conclusion Puerarin can lower the expression of GSK- 3 in the skeletal muscle of rats with insulin resistance, consequently promoting the ingestion and utilization of glucose and improving the insulin resistance.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To observe the effects of puerarin on the expression of glycogen synthase kinase- 3 (GSK- 3) in the skeletal muscle of rats with insulin resistance induced by high fat and sucrose diets. Methods 30 Wistar rats were randomly divided into three groups: normal group, model group and puerarin group, 10 rats in each group. The model group and puerarin group were fed with the high fat and sucrose diets for 4 weeks. Then puerarin group was treated with puerarin by abdominal injection (100 mg/kg) for 6 weeks. At the end of the experiment, GSK- 3 content was detected by Western blot analysis. Body weight, serum triglyceride and cholesterol levels, fasting plasma glucose and serum insulin concentrations were measured regularly and insulin sensitivity index was also computed as well. Results The outcome of Western blot analysis showed that the expression of GSK- 3 in the skeletal muscle of the model group increased by 70.20 % (P 0.01) compared with the normal group. After 6 weeks of puerarin treatment, the GSK- 3 content in the skeletal muscle of the puerarin group decreased by 26.54 % (P 0.01) compared with the model group and increased by 25.02 % (P 0.05) compared with the normal group. Conclusion Puerarin can lower the expression of GSK- 3 in the skeletal muscle of rats with insulin resistance, consequently promoting the ingestion and utilization of glucose and improving the insulin resistance.

Key concepts: Puerarin, Insulin resistance, Internal medicine, Endocrinology, Skeletal muscle, Insulin, Triglyceride, Glycogen synthase

Related papers

Back to paper searchBrowse research topicsOriginal source
Effects of Puerarin on the Expression of Glycogen Synthase Kinase- 3 in Skeletal Muscle of Rats with Insulin Resistance — Research Paper | ScholarLens